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Background: Increased body weight may influence airway inflammatory mechanisms.
Objective: To assess whether overweight–obesity (OW-O), evaluated as increased body mass index, is associated either with
exhaled nitric oxide (eNO), a marker of airway inflammation, or with allergic sensitization in a large sample of children and
adolescents.
Methods: A cross-sectional, epidemiological study was performed on a population sample of schoolchildren evaluating 708
subjects (age 10–16 years; BMI 13–39 kg/m2) by respiratory health questionnaire, skin prick tests, spirometry, and eNO measure.
Results: Prevalence rates were: OW-O 16.4%, asthma ever (A) 11.9%, and rhinoconjunctivitis (RC) 14.8%. Asthma ever and
allergic sensitization were significantly more frequent among OW-O (21.0 and 51.6%) than in non–OW-O (10.2 and 37.0%,
respectively). The forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) ratio was not significantly different
between OW-O and non–OW-O. Exhaled NO (median and interquartile range) was 15.3 (11.2–23.1) ppb in the overall sample,
20.3 (12.9–35.8) ppb among allergic subjects, and 13.9 (10.6–18.3) ppb among nonallergic subjects (P.0001). No significant
difference between OW-O and non OW-O subjects was found in eNO levels. Similarly, OW-O subjects with A or RC did not
show significantly higher eNO levels than non–OW-O. In a logistic regression model, presence of allergic sensitization, A, and
RC, and not OW-O, were significant predictors of increased eNO.
Conclusions: In children, OW-O was not associated with increased eNO levels, but it was an independent risk factor for
asthma and allergic sensitization.
Ann Allergy Asthma Immunol. 2011;107:330–336.
INTRODUCTION
Epidemiological surveys have shown a trend to increasing
prevalence of asthma1 and obesity2 over the last decades.
Because both asthma and obesity are characterized by inflam-
matory processes, mechanisms based on common pathways,
such as endocrine factors including adipokines and reproduc-
tive hormones,3 have been proposed as a plausible explana-
tion for the association between the 2 conditions.4,5 In fact, a
higher adiposity in infancy has been recently demonstrated to
be associated with increased risk of recurrent wheezing dur-
ing childhood,6 and increased body weight may influence
airway inflammatory mechanisms,7 even though underlying
mechanisms have not been completely elucidated.8
Exhaled nitric oxide (eNO) is a useful noninvasive marker of
airway inflammation,9 particularly in children with asthma.10 A
highly significant correlation with blood eosinophilia was found
in children with mild to moderate persistent asthma followed by
the Childhood Asthma Research and Education Network sup-
ported by the National Heart, Lung, and Blood Institute.11 In-
deed, the interest in eNO is based on the assumptions that eNO
is a marker of asthma and asthma control, and that it reflects
eosinophilic airway inflammation. However, the literature re-
mains inconclusive.12
Few studies have investigated the relationships between
body mass index (BMI) and eNO in pediatric populations. In
40 nonatopic children (range, 6–18 years) with no history of
respiratory diseases, no relationship was detected between
eNO and age- and sex-corrected body mass index.13 In addi-
tion, when asthma was taken into account, eNO levels did not
differ between obese and nonobese asthmatic children.14 Sim-
ilarly, eNO was not correlated to adiposity among adoles-
cents with moderate to severe asthma.15
Although allergic sensitization is an important phenotype
in children with asthma and a factor able to influence eNO
levels per se,16 few and controversial data exist on the rela-
tionship between obesity and atopy. In fact, an increased BMI
was a significant predictor of atopy in children,17 but only in
girls. Conversely, no association was found between BMI and
self-reported allergy in a large Italian population sample.18
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iSimilarly, no independent relationship between BMI and
atopy—as assessed by skin prick tests—was found in US
children.19
Thus, the association of increased body weight with aller-
gic sensitization, elevated eNO, and asthma symptoms is
controversial. These factors—body weight, eNO, allergic
sensitization, and asthma symptoms—have not been evalu-
ated simultaneously from a general population sample of
older children.
The aim of our cross-sectional study was to assess whether
overweight–obesity (OW-O) per se is associated with higher
exhaled nitric oxide or increased prevalence of allergic sen-
sitization and asthma in a large sample of schoolchildren aged
10 to 16 years, investigated by means of questionnaires,
spirometry, and skin prick tests.
METHODS
Patient Population
This cross-sectional study was carried out in a general pop-
ulation sample of 10- to 16-year-old schoolchildren from 16
schools selected on the basis of their geographical distribu-
tion among the 59 junior high schools of Palermo (680,000
inhabitants), Southern Italy, during November 2005 to May
2006. The entire student population of the 16 schools was
9,922 children. From this group, we randomly selected 2,481
children (1 of every 4). Three hundred three children did not
obtain parental consent or were not present at school in the
day of the study. Thus 2,178 children completed a respiratory
health questionnaire and underwent lung function testing and
skin prick test (SPT) at school. Among them, 28 children
refused SPT or were not able to perform a valid spirometry.
Finally, 2,150 children were completely evaluated by ques-
tionnaire, lung function testing, and SPT at school.
Except for asthma, no other chronic pulmonary disease
was reported.
Study Parameters
Following the Italian SIDRIA Study (Studio Italiano Disturbi
Respiratori Infanzia e Ambiente),20 which, in turn, adopted
the standardized method of the International Study of Athma
and Allergies in Childhood,21 a child’s history of “asthma
ever” was defined as a positive answer to the question “Have
you ever had asthma?” Rhinoconjunctivitis was defined as a
positive answer to both the questions “Have you ever had a
problem with sneezing, or runny, or blocked nose apart from
common cold or flu in the last 12 months?” and “In the past
12 months, has this nose problem been accompanied by
itching and/or watering eyes?” For the analyses, 3 subgroups
were considered: patients with asthma, regardless of the pres-
ence of rhinoconjunctivitis (A); subjects with rhinoconjunc-
tivitis (RC); and subjects without asthma or RC (nAnRC).
Consequently, individuals with both asthma and rhinocon-
junctivitis were classified as A, whereas RC included only
subjects with rhinoconjunctivitis alone.
Skin prick tests were performed according to European
Academy of Allergy and Clinical Immunology recommenda- c
VOLUME 107, OCTOBER, 2011ions22 with a standard panel including Dermatophagoides
ix, grass mix, Parietaria judaica, olive, dog and cat dander,
lternaria alternata, and Blattella germanica, plus a positive
histamine 1%) and a negative (saline) control (Stallergènes
talia S.r.l., Milan, Italy). The reading was performed after 15
inutes: reactions were considered positive if the mean
heal diameter (computed as the maximum diameter plus its
rthogonal divided by 2) was 3 mm or larger, after having
ubtracted the wheal diameter of the reaction to the negative
ontrol. Allergic sensitization was defined as the presence of
t least 1 positive skin prick test.
Height and weight were measured in all of the children in
tanding position without shoes, using a stadiometer and an
lectronic digital scale: BMI was computed as weight/height2
kg/m2). Overweight-obese children were defined as BMI
arger than the age- and sex-specific 85th percentiles of the
tudied population sample.23
Pulmonary function tests were performed by a portable
pirometer (MicroLoop, Micro Medical, Chatham Maritime,
ent, United Kingdom). Forced expiratory volume in 1 sec-
nd (FEV1), forced vital capacity (FVC) and maximum mid-
xpiratory flow (FEF25–75%) were measured according to
merican Thoracic Society and European Respiratory Soci-
ty guidelines: The best FVC and FEV1 were retained, and
EF25–75% was selected from the maneuver with the largest
um of FEV1 and FVC.24 The FEV1/FVC% ratio was com-
uted as best FEV1/best FVC. Spirometric predicted values
ere those from Pistelli et al.,25 derived from an Italian
opulation sample. An impaired pulmonary function was
efined when FEV1/FVC% was below the 5th percentile of its
ormal distribution (87% of predicted for boys and 90% for
irls).25
itric Oxide Measurements
ecause we could not study the entire sample by eNO anal-
sis, because of resources limitations, among 2,150 subjects
ho completed the baseline evaluation, 717 children were
andomly selected (one every three subjects) and evaluated
y off-line eNO measurements using single exhalations with
onstant flow by a dynamic-flow restrictor following Amer-
can Thoracic Society and the European Respiratory Society
ecommendations.26 The exhaled gas was collected into NO-
nert 4-L mylar bags27 and analyzed within 4 hours by a
hemiluminescence analyzer connected to a computerized
ystem (NIOX, Aerocrine AB, Stockholm, Sweden). The
nstrument had a sensitivity of 1.5 part per billion (ppb), a
etection range of 0 to 200 ppb, and a response time of less
han 0.8 s, and was calibrated with a certified NO gas mix-
ure. Finally, 9 individuals were not able to perform a valid
aneuver; thus, 708 children had eNO data were available
or the analysis.
The study was approved by the Institutional Review Board
f the University Hospitals of Palermo, and all children had
written informed consent signed by a parent. The respect of
ndividual privacy concerning clinical data was granted ac-
ording to the Italian law.
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One-way and two-way analysis of variance (ANOVA) and
frequency distribution tables (2) for parametric variables
were performed: because the distribution of eNO values was
highly skewed, analysis was performed after natural log
transformation (ln eNO). Nonparametric Mann-Whitney U-
test was used when appropriate. To study the independent
variables able to influence the risk for elevated eNO levels,
eNO was dichotomized at the level of its 75th percentile, and
a logistic regression model was used to explore the relation-
ships between the dependent variable (eNO) and independent
variables (BMI, impaired lung function, atopy, presence of
asthma, or rhinitis), adjusting for sex. Odds ratios with cor-
responding 95% confidence intervals (CI) were calculated for
all predictors. All computations were performed by StatView
statistical software package (SAS Institute, Cary, North Car-
olina). A probability level of P  .05 was selected as being
statistically significant.
RESULTS
The 708 subjects who performed eNO measurements (352
males, 49.7%) were not significantly different compared with
the whole population sample (N  2,150) as concerns age,
sex, allergic sensitization, BMI, symptoms, and lung function
(Table 1). One hundred sixteen (16.4%) overweight-obese
subjects (OW-O) were included, with no significant differ-
ence by sex (P  .10, 2), 84 (11.9 %) subjects with A, 105
(14.8%) with RC, and 519 (73.3 %) nAnRC.
Percent predicted FEV1/FVC ratio was significantly re-
duced among A subjects (97.5  7.7%) compared with both
RC (100.4  7.0%, P  .002) and nAnRC (101.1  6.3%,
P  .0001) by ANOVA. Similarly, FEF25/75% (%pred) was
lower in A (76.1  19.7%) compared with RC (84.5  20.4,
P  .002) and nAnRC (85.5  18.6, P  .0001). No
significant difference was found for both FEV1/FVC and
FEF25/75% between nAnRC and RC.
Prevalence rates of A and allergic sensitization were sig-
nificantly higher in OW-O than in non-OW-O (2, Table 2).
Table 1. Descriptive Data of the Total Sample and Study Population
T
Subject (No.)
Males (No., %)
Age, yrs (mean, range)
Asthmatics (No., %)
Rhinoconjunctivitis (No., %)
Allergic sensitization (No., %)
FVC %pred (mean  SD)
FEV1 %pred (mean  SD)
FEF25/75% %pred (mean  SD)
FEV1/FVC %pred (mean  SD)
Impaired lung function (No., %)
BMI (kg/m2, mean  SD)
Overweight-obese children (No., %)a
All the differences were not statistically significant (2 test for catego
a Overweight-obese children were defined as BMI greater than the age- and
332ercent predicted FEV1 and FVC were significantly lower in
W-O than non-OW-O, whereas no significant difference
as found for FEV1/FVC and FEF25–75% (percent predicted)
Table 2).
Exhaled nitric oxide (median and interquartile range) was
5.3 (11.2–23.1) ppb in the study population, with no signif-
cant difference between OW-O (15.0 [11.6–22.3] ppb) and
on-OW-O subjects (15.5 [11.2–23.3] ppb) (P  .87, Mann-
hitney U-test, Table 2). Similarly, obesity was not associ-
ted with increased eNO in A, RC, and nAnRC subgroups
ompared with nonobese (Mann-Whitney U-test, Table 3A).
oreover, no difference was found in distribution of subjects
ith allergic sensitization between OW-O and non-OW-O in
oth A and RC subgroups (Table 3B).
In a two-way ANOVA model, allergic sensitization but not
W-O was associated with a significant increase of eNO (Fig
). In fact, exhaled nitric oxide (median and interquartile
ange) was 20.3 (12.9–35.8) ppb among subjects with posi-
ive SPT and 13.9 (10.6–18.3) ppb among subjects without
ositive SPT (P  .0001, ANOVA, after natural log trans-
ormation). When the combination of asthma ever and aller-
ic sensitization was taken into account, eNO was not sig-
ificantly more elevated in OW-O children (Fig 2).
When evaluated in different logistic models, OW-O was a
ignificant risk factor for both A (Table 4) and allergic
ensitization (Table 5). By a logistic regression model, pres-
nce of allergic sensitization, asthma ever, and rhinoconjunc-
ivitis were significant predictors of increased eNO. In the
ame model, neither OW-O nor impaired lung function were
ignificant risk factors for increased eNO (Table 6).
ISCUSSION
n this cross-sectional study of schoolchildren, aged 10 to 16
ears, no evidence of eosinophilic airway inflammation, as
valuated through exhaled nitric oxide measurements, was
ound in overweight-obese children. Nevertheless, we con-
irmed that OW-O was associated with asthma ever and
llergic sensitization (Fig 3). Moreover, asthma, rhinocon-
opulation sample Study population
2,150 708
,057 (49.2) 352 (49.7)
12.6 (10–18) 12.6 (10–16)
259 (12.0) 84 (11.9)
326 (15.2) 105 (14.8)
839 (39.2) 280 (39.5)
92.2  11.8 91.5  11.4
90.3 11.4 89.7  11.1
84.8  19.1 84.2  19.2
00.5  6.5 100.6  6.7
90 (4.2) 31 (4.3)
21.3  4.3 21.4  4.5
323 (15.0) 116 (16.4)
riables and ANOVA for continuous variables).otal p
1
1
rical va
sex- specific 85th percentiles of the studied population sample.27
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9junctivitis, and, mainly, allergic sensitization were indepen-
dent risk factors for increased eNO levels. No significant
effect of pulmonary function on exhaled NO levels was
found.
Although BMI is only a proxy for adiposity,28 it is easy to
Table 2. Distribution of allergic sensitization, A, RC, Respiratory Sym
and Overweight-Obese (OW-O) Subgroups
Non O
A (No., %) 6
RC (No., %) 11
FVC %pred (mean  SD) 9
FEV1 %pred (mean  SD) 9
FEV1/FVC %pred (mean  SD) 10
FEF25/75% %pred (mean  SD) 8
Allergic sensitization (No., %) 21
eNO (ppb, median and interquartile range) 15.
A, asthmatic subjects; RC, subjects with rhinoconjunctivitis.
a 2 test.
b One-way ANOVA.
c Mann-Whitney U-test.
Table 3. Exhaled NO Levels (A) and Distribution of Subjects with Alle
Obese Subjects (Non OW-O), in Asthmatic, Rhinoconjunctivitis, and
A—Exhaled NO levels
nAnRC subjects (ppb, median and interquartile range)
Rhinoconjunctivitis (ppb, median and interquartile range)
Asthmatics (ppb, median and interquartile range)
a Mann-Whitney U-test.
B—Subjects with allergic sensitization
nAnRC subjects (%)
Rhinoconjunctivitis (%)
Asthmatics (%)
b 2 test.
Figure 1. Nitric oxide values for overweight-obese (OW-O) and non-
obese (non OW-O) individuals, by presence/absence of allergic sensitization.
P  .17 for obesity, P  .0001 for allergic sensitization, two-way ANOVA,
after natural log transformation. Bars indicate (from the bottom to the top)
10th, 25th, 50th (median), 75th, and 90th percentiles. Values below the 10th and
above the 90th percentiles are plotted as circles.measure in epidemiological studies. Because BMI changes o
VOLUME 107, OCTOBER, 2011ignificantly with age and sex in childhood,29 overweight–
besity cutoff levels were selected according to the age- and
ex-related 85th percentiles of the BMI distribution computed
, and Respiratory Function in Non–Overweight-Obese (Non OW-O)
N  592) OW-O (N  116) P
) 24 (21.0) .0008a
) 21 (17.7) .61a
11.3 87.5  11.1 .0001b
11.2 87.8  10.4 .03b
6.5 101.2  7.8 .27b
19.1 82.9  19.8 .42b
) 60 (51.6) .0023a
–23.3) 15.0 (11.6–22.3) .87c
nsitization (B) Separately for Overweight-Obese (OW-O) and Non-
l (Normal - nAnRC) Subgroups
Non OW-O OW-O Pa
15.0 (11.1–20.7) 13.3 (11.4–19.6) .48
16.1 (10.9–26.7) 18.3 (11.4–28.7) .72
22.4 (12.6–44.2) 17.4 (13.5–27.6) .44
OW-O OW-O Pb
3.1 47.6 .01
0.6 56.3 .24
0.0 61.5 .89
Figure 2. Nitric oxide values for overweight-obese (OW-O) and non-obese
non OW-O) individuals, separately for any combination of presence of asthma
ver and allergic sensitization. Two-way ANOVA, after natural log transforma-
ion. Bars indicate (from the bottom to the top) 10th, 25th, 50th (median), 75th, and
0th percentiles. Values below 10th and above 90th percentiles are plotted as circles.ptoms
W-O (
1 (10.3
7 (19.7
2.3 
0.1 
0.5 
4.4 
9 (37.0
5 (11.2rgic Se
Contro
Non
3
4
6n the whole sample. Indeed, a BMI greater than 85th per-
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icentile yields an elevated specificity for identifying subjects
with increased body fat,30 also ensuring a sufficient number
of OW-O for statistical comparisons.
The prevalence of OW-O was 16.4% among our study
population. This subgroup showed higher prevalence rates of
asthma ever and allergic sensitization. Asthma ever was ap-
proximately twofold more frequent among OW-O compared
with non-OW-O subjects, in agreement with the results of a
recent meta-analysis providing the evidence for the associa-
tion of asthma and obesity.31 However, controversial results
exist in children,32,33 possibly depending on different ap-
proaches to asthma and obesity definitions, muscle mass, or
Table 4. Multiple Logistic Regression Analysis for the Effect of Sex,
Parental History of Asthma, Allergic Sensitization, Presence of
Rhinoconjunctivitis, and Overweight-Obesity (OW-O) on Asthma
Ever
OR 95% CI P
Sex (M vs F) 1.22 0.77–1.95 .40
Parental history for asthma 3.36 1.90–5.94 .0001
Allergic sensitization 2.22 1.39–3.55 .0009
Rhinoconjunctivitis 2.76 1.68–4.52 .0001
OW-O 2.23 1.32–3.78 .0029
Data are expressed as odds ratio (OR) and 95% confidence interval
(95% CI).
Table 5. Multiple Logistic Regression Analysis for the Effect of
Overweight-Obesity (OW-O), Presence of Asthma Ever,
Rhinoconjunctivitis, and Increased eNO Levelsa on Allergic
Sensitization
OR 95% CI P
OW-O 1.89 1.24–2.89 .003
Sex 1.52 1.10–2.09 .012
Asthma ever 1.74 1.04–2.90 .034
Increased eNO levels§ 5.45 3.75–7.91 .0001
Data are expressed as odds ratio (OR) and 95% confidence interval
(95% CI) and corrected for impaired lung function and presence of
rhinoconjunctivitis.
a Cutoff level at 75th percentile of eNO distribution.
Table 6. Multiple Logistic Regression Analysis for the Effect of
Overweight-Obesity (OW-O), Presence of Asthma Ever,
Rhinoconjunctivitis, and Allergic Sensitization on Increased eNO
Levelsa
OR 95% CI P
OW-O 0.65 0.39–1.07 .088
Asthma ever 2.01 1.19–3.38 .009
Rhinoconjunctivitis 1.91 1.24–2.93 .003
Allergic sensitization 5.45 3.75–7.91 .0001
Data are expressed as odds ratio (OR) and 95% confidence interval
(95% CI) and corrected for sex and impaired lung function.
a Cutoff level at 75th percentile of eNO distribution.hormone-related differences.34 o
334We found an association between OW-O and asthma in our
choolchildren regardless of sex (Table 4). Conversely, Gil-
iland et al23 reported an increased risk of new-onset asthma
n overweight and obese boys, and Schachter et al17 did not
ind any association between high BMI and diagnosed or
urrent asthma in 7- to 12-year-old children, in either boys or
irls. Different asthma definitions, resulting in different
sthma prevalence, and different population samples can ac-
ount for these controversial results.
Considering airway caliber indicators, OW-O subjects did
ot show significantly reduced FEV1/FVC and FEF25/75% ei-
her in the overall sample or in the asthmatic subgroup,
uggesting that OW-O does not produce per se any significant
ffect on airway obstruction. Considering lung volume indi-
ators, the significant FEV1 and FVC decreases (as percent-
ge of predicted), at a similar extent, in OW-O could be
ttributable to a limited expansion of the lungs as an effect of
hest compression.35 Our findings are in agreement with the
esults reported by Li et al,36 who did not find any correlation
etween obesity and both FEV1 and FVC in a sample of
bese children. Conversely, our findings differ from those of
hen et al,37 who found a negative correlation between obe-
ity, as measured by waist circumference, and FEV1/FVC,
nd from those of Kattan et al,15 reporting worse asthma
ontrol and poorer pulmonary function in female obese ado-
escents. In the latter paper, possible sex-related mechanisms
other than atopy and inflammation) were advocated for
xplaining these differences.
We found a significantly higher prevalence of subjects
ith allergic sensitization in OW-O (51.6%) compared with
onobese (37.0%). Controversial results have been reported
n previous pediatric studies: allergic sensitization was not
ncreased in OW-O,34 and atopic girls (not boys) were more
requent among subjects with high BMI.17
Exhaled NO values do not significantly differ between
W-O and subjects with a normal weight both in the whole
ample and in the subgroups with asthma ever or rhinocon-
unctivitis. These results are consistent with a recent study
eporting no significant differences in eNO values in obese
ealthy children compared with nonobese controls.38 Simi-
arly, Buchvald et al39 showed that eNO levels were not
elated to BMI in 4- to 17-year-old healthy children. More-
Figure 3. Effect of overweight–obesity (OW-O) on the investigated
ariables. OW-O was not associated with increased exhaled nitric oxide
eNO) levels, but it was an independent risk factor for asthma ever and
llergic sensitization, which, in turn, were independently associated with
ncreased eNO levels.ver, no significant relationship between eNO and BMI was
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2found in asthmatic subjects,40 and childhood obesity was not
associated with increased airway inflammation.41 Conversely,
De Winter-de Groot et al42 showed that exhaled nitric oxide
was positively associated with BMI in healthy adults and
suggested a direct or indirect upregulation of inflammatory
processes in the airways influenced by obesity. However,
individual atopic status was not evaluated, and BMI was
limited to the range 18 to 29 kg/m2.
We found that OW-O was not associated with a significant
increase in eNO in the total sample, nor in each A, RC, or
nAnRC subgroup. Similarly, eNO was not significantly dif-
ferent among OW-O subjects in any combination of presence
of asthma ever and allergic sensitization (Fig 2). A possible
explanation for this result might be an information bias (eg,
overdiagnosis of asthma attributable to nonspecific obesity-
related respiratory symptoms among obese children). In fact,
recent meta-analyses have pointed out that some obese pa-
tients with “asthma” may have respiratory symptoms caused
by obesity without objective physiological criteria for
asthma3 or an exaggerated symptom perception.4
Asthma ever, rhinoconjunctivitis, and, mainly, allergic sen-
sitization were the only variables able to significantly in-
crease the risk for a high eNO level, as already demonstrated
in a study on a general population sample previously con-
ducted by our group.16 Despite the fact that in the current
sample no different marker of airway inflammation was
available, we believe, as repeatedly reported in the literature,
that allergic sensitization is one of the single most important
factors affecting the association between eNO and different
markers of eosinophilia.11,12 In other words, a correct inter-
pretation of eNO values should always be based on the
knowledge of the atopic status of investigated subjects.
Thus, in view of the results of the applied methods, we
cannot share the hypothesis that, in overweight-obese chil-
dren, systemic inflammatory mechanisms of obesity may
produce an increase in eosinophilic airway inflammation, as
recently suggested by Sutherland et al.7 Moreover, the lack of
increased bronchial hyperresponsiveness in obese children17
further supports the hypothesis that obesity and airway in-
flammation are not associated conditions. Conversely, a re-
cent report from Wood et al43 suggests that high-fat meals
may augment neutrophilic airway inflammation. This contro-
versial experimental evidence suggests that additional inves-
tigation is required for exploring common pathways possibly
linking adiposity and airway inflammation.
In conclusion, our findings suggest that overweight–obe-
sity per se does not have a significant effect on airway
inflammation as measured by exhaled nitric oxide in a large
sample of children and adolescents. However, our study
confirms that overweight–obesity is an independent risk fac-
tor for asthma and allergic sensitization, which, in turn, are
associated with airway inflammation. Thus, among older
children, overweight–obesity may represent a significant bur-
den for later health consequences.
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